| Issue Date | Title | Author(s) |
| Sep-2013 | 5-Fluorouracil signaling through a calcium-calmodulin-dependent pathway is required for p53 activation and apoptosis in colon carcinoma cells | Can, G.; Akpınar, B.; Baran, Yusuf ; Zhivotovsky, B.; Olsson, M. |
| 2009 | Accumulation of apoptotic ceramides increased apoptotic effects of nilotinib in Philadelphia positive MEG-01 cells synergistically | Baran, Yusuf ; Gençer, Emel Başak; Ural, Ali Uğur; Avcu, Ferit |
| 2010 | Activated signaling pathways and apoptotic mechanisms in resveratrol applied chronic myeloid leukemia cells and the involvement of ceramide metabolizing genes on these mechanisms | Kartal Yandım, Melis |
| 2021 | Advantage of co-culture strategy for targeted cancer treatment and in vitro studies | Ulu, Gizem Tuğçe ; Bayram, Nazende Nur; Dinçer İşoğlu, Sevil; Baran, Yusuf |
| May-2018 | An answer to colon cancer treatment by mesenchymal stem cell originated from adipose tissue | İplik, Elif Sinem; ERtuğrul, Barış; Kozanoğlu, İlknur; Baran, Yusuf |
| 29-Jun-2015 | Anti-proliferative, apoptotic and signal transduction effects of hesperidin in non-small cell lung cancer cells | Çinçin, Zeynep Birsu; Ünlü, Miray ; Kıran, Bayram; Bireller, Elif Sinem; Baran, Yusuf ; Çakmakoğlu, Bedia |
| 2015 | Antiproliferative and apoptotic effects of ponatinib and its effects on macromolecular changes in imatinib-sensitive and resistant chronic myeloid leukemia (CML) cell lines: a mechanistic approach | Kartal Yandım, Melis; Ceylan, Çağatay ; Elmas, Efe; Baran, Yusuf |
| 2012 | Antiproliferative and apoptotic effects of resveratrol on chronic lymphocytic leukemia cells | Baran, Yusuf ; Gökbulut, Aysun ; Özcan, Mehmet Ali; Pişkin, Özden; Ünlü, Miray |
| Feb-2016 | Apoptotic effects of non-edible parts of Punica granatum on human multiple myeloma cells | Kiraz, Yağmur ; Neergheen-Bhujun, Vidushi S.; Rummun, Nawraj; Baran, Yusuf |
| Aug-2014 | Apoptotic effects of quercitrin on DLD-1 colon cancer cell line | Çinçin, Zeynep Birsu; Ünlü, Miray ; Kıran, Bayram; Bireller, Elif Sinem; Baran, Yusuf ; Çakmakoğlu, Bedia |
| 2010 | Apoptotic effects of resveratrol on imatinib sensitive and resistant K562 chronic myeloid leukemia cells | Baran, Yusuf ; Can, Geylani |
| Jul-2012 | Apoptotic effects of resveratrol, a grape polyphenol, on imatinib-sensitive and resistant K562 chronic myeloid leukemia cells | Can, Geylani; Çakır, Zeynep; Kartal, Melis; Gündüz, Ufuk; Baran, Yusuf |
| Jun-2013 | Autologous rabbit adipose tissue-derived mesenchymal stromal cells for the treatment of bone injuries with distraction osteogenesis | Sunay, Özgür; Can, Geylani; Çakır, Zeynep; Denek, Ziya; Kozanoglu, İlknur; Erbil, Güven; Yılmaz, Mustafa; Baran, Yusuf |
| 2012 | Autophagic and apoptotic effects of tyrosine kinase inhibitors in myeloid leukemia: Comparison of three generation | Kayabaşı, Çağla; Avcı, Çığır Biray; Süslüer, Sunde Yılmaz; Balcı, Tuğçe; Baran, Yusuf ; Saydam, Güray; Gündüz, Cumhur |
| Mar-2012 | Bioactive sphingolipids in docetaxel-induced apoptosis in human prostate cancer cells | Başsoy, Esen Yonca; Baran, Yusuf |
| May-2011 | Bioactive sphingolipids in response to chemotherapy: A scope on Leukemias | Ekiz, Hüseyin Atakan ; Baran, Yusuf |
| May-2014 | Bioactive, functional and edible film-forming properties of isolated hazelnut (Corylus avellana L.) meal proteins | Aydemir, Levent Yurdaer; Adan Gökbulut, Aysun ; Baran, Yusuf ; Yemenicioğlu, Ahmet |
| Nov-2017 | Biodiversity, drug discovery, and the future of global health: Introducing the biodiversity to biomedicine consortium, a call to action | Neergheen-Bhujun, Vidushi; Awan, Almas Taj; Baran, Yusuf ; Bunnefeld, Nils; Chan, Kit; Dela Cruz, Thomas Edison; Egamberdieva, Dilfuza; Elsasser, Simon; Johnson, Mari-Vaughn V.; Komai, Shoji; Konevega, Andrey L.; Malone, John H.; Mason, Paul; Nguon, Rothsophal; Piper, Ross; Shrestha, Uttam Babu; Pesic, Milica; Kagansky, Alexander |
| Mar-2023 | Biodiversity: the overlooked source of human health | Linhares, Yuliya; Kaganski, Alexander; Agyare, Christian; Aksan Kurnaz, Işıl; Neergheen, Vidushi; Kolodziejczyk, Bartlomiej; Baran, Yusuf |
| Sep-2008 | Bisphosphonate treatment and radiotherapy in metastatic breast cancer | Ural, Ali Uğur; Avcu, Ferit; Baran, Yusuf |
| 2012 | Biyolojik-kimyasal reaksiyonların benzetimi için Monte Carlo teknikleri | Altınkaya, Mustafa Aziz ; İnal, Fikret ; Baran, Yusuf |
| 2011 | Caffeic acid phenethyl ester triggers apoptosis through induction of loss of mitochondrial membrane potential in CCRF-CEM cells | Avcı, Çığır Biray; Gündüz, Cumhur; Baran, Yusuf ; Şahin, Fahri; Yılmaz, Sunde; Doğan, Zeynep Özlem; Saydam, Güray |
| Nov-2016 | Cell proliferation and cytotoxicity assays | Adan, Aysun ; Kiraz, Yağmur ; Baran, Yusuf |
| 2010 | Ceramides regulate resveratrol-induced apoptosis in human acute promyelocytic and chronic myeloid leukemia cells | Baran, Yusuf ; Kartal, Melis; Çakır, Zeynep; Saydam, Güray; Şahin, Fahri |
| 2010 | Changes in expression profiles of apoptosis, invasion, metastasis, angiogenesis, transcription factors, cell cycle control and tumour supressor genes in nilotinib treated chronic myeloid leukemia cells | Baran, Yusuf ; Camgöz, Aylin; Can, Geylani |
| 2013 | Changes in gene expression profiles in response to apigenin in imatinib sensitive and resistant chronic myeloid leukemia cells | Baran, Yusuf ; Gökbulut, Aysun ; Cincin, Zeynep; Çakmakoğlu, Bedia; Kozanoğlu, İlknur |
| 2013 | Changes in molecular biology of chronic myeloid leukemia in tyrosine kinase inhibitor era | Cömert, Melda; Baran, Yusuf ; Saydam, Güray |
| May-2013 | Changes in protein profiles of multiple myeloma cells in response to bortezomib | Turan, Taylan; Şanlı Mohamed, Gülşah ; Baran, Yusuf |
| Jun-2010 | Combination of fludarabine and imatinib induces apoptosis synergistically through loss of mitochondrial membrane potential and increases in caspase-3 enzyme activity in human K562 chronic myleloid leukemia cells | Baran, Yusuf ; Öztekin, Coşkun; Başsoy, Esen Yonca |
| Sep-2014 | Comparative development of knowledge-based bioeconomy in the European Union and Turkey | Çelikkanat Ozan, Didem; Baran, Yusuf |
| 2014 | Comparison of ishage-based CD34 (+) cell enumeration protocols on BD facs canto ıı and attune flow cytometers | Kozanoğlu, İlknur; Ünver, Gülşah; Sarıtürk, Çağla; Baran, Yusuf ; Yeral, Mahmut; Boğa, Can; Özdoğu, Hakan |
| 2012 | Cumulative clinical experience from a decade of use: imatinib as first-line treatment of chronic myeloid leukemia | Baran, Yusuf ; Saydam, Güray |
| 2014 | Cytotoxic and apoptotic effects of fisetin, hesperetin and vitexinon acute promyelocytic leukemia cells | Adan Gökbulut, Aysun ; Baran, Yusuf |
| 2014 | Cytotoxic and cytostatic effects of ponatinib on imatinib-sensitive and-resistant chronic myeloid leukemia cells | Yandım, Melis Kartal; Baran, Yusuf |
| 2013 | Cytotoxic effects of apigenin on multiple myeloma cells | Baran, Yusuf ; Yılmaz, S. ; Cincin, Zeynep; Kozanoğlu, İlknur; Çakmakoğlu, Bedia; Özdoğu, Hakan |
| 2010 | Cytotoxic effects of resveratrol on imatinib sensitive and resistant K562 chronic myeloid leukemia cells | Can, Geylani; Baran, Yusuf |
| 2011 | Deciphering 5-fluorouracil mediated molecular mechanisms required for cell death | Can, Geylani |
| 2013 | Determination of cytotoxic and apoptotic effects of caffeic acid phenethyl ester and gossypol in combination with fludarabine at a molecular level in acute lymphoblastic leukemia cells | Baran, Yusuf ; İskender, G.; Pişkin, Özden; Özcan, Mehmet Ali |
| Jul-2021 | Determination of therapeutic effects of multifunctional antibody and peptide micelle-based nanocarriers on breast cancer cells | Abdulhadi, Nusaibah Abdulsalam Abdulhad |
| 2021 | Determination of therapeutic effects of multifunctional micelle-based nanocarriers on breast cancer cells | Ulu, Gizem Tuğçe ; Bayram, Nazende Nur; Abdulhadi, N.; Gurdap, S.; Isoglu, A.; Isoglu, S. D.; Baran, Yusuf |
| Jul-2019 | Determination of therapeutic effects of multifunctional micelle-based nanocarriers on breast cancer cells | Ulu, Gizem Tuğçe |
| Dec-2019 | Determination of therapeutic potential of apigenin on acute lymphoblastic leukemia cells | Uzuner, Erez |
| Nov-2019 | Determination of therapeutic potential of luteolin for acute lymphoblastic leukemia cells | Gürler, Sevim Beyza |
| 2020 | Determination of therapeutic potential of luteolin for Philadelphia chromosome positive acute lymphoblastic leukaemia cells | Gürler, Sevim Beyza; Baran, Yusuf ; Kiraz, Yağmur |
| 2013 | Diagnostic and therapeutic potentials of expression levels of bioactive sphingolipid genes in newly diagnosed and drug-resistant chronic myeloid leukemia patients | Baran, Yusuf ; Yandım, Melis; Kozanoğlu, İlknur; Özdoğu, Hakan; Pişkin, Özden; Özcan, Mehmet Ali |
| 2015 | Discovering alternative targets in chronic myeloid leukemia (CML): determination of expression levels of bioactive sphingolipid genes in newly diagnosed and drug-resistant CML patients | Kartal Yandım, Melis; Kozanoğlu, İlknur; Özdoğu, Hakan; Pişkin, Özden; Özcan, Mehmet Ali; Baran, Yusuf |
| Jun-2009 | Docetaxel enhances the cytotoxic effects of imatinib on Philadelphia positive human chronic myeloid leukemia cells | Güçlüler, Gözde; Baran, Yusuf |
| Feb-2009 | Docetaxel/zoledronic acid combination triggers apoptosis synergistically through downregulating antiapoptotic Bcl-2 protein level in hormone-refractory prostate cancer cells | Karabulut, B.; Erten, C.; Gül, M. K.; Cengiz, E.; Karaca, B.; Küçükzeybek, Y.; Görümlü, G.; Atmaca, H.; Uzunoğlu, S.; Şanlı, U. A.; Baran, Yusuf ; Uslu, R. |
| Jul-2011 | Effect of cobalt-60 (? radiation) on multidrug-resistant multiple myeloma cell lines | Mutlu, Pelin; Baran, Yusuf ; Ural, Ali Ugur; Avcu, Ferit; Dirican, Bahar; Beyzadeoglu, Murat; Gündüz, Ufuk |
| Sep-2017 | Effect of molecular architecture on cell interactions and stealth properties of PEG | Özer, İmran; Tomak, Aysel ; Zareie, Hadi M.; Baran, Yusuf ; Bulmuş, Volga |
| 2013 | Effect of nilotinib on the function of carotid artery endothelial cells | Katgı, Abdullah; Gökbulut, Aysun ; Sevindik, Ömer; Yüksel, Faize; Solmaz, Şerife; Özsan, Güner; Baran, Yusuf ; Pişkin, Özden |
| 2013 | Effects of apigenin on imatinin-sensitive and resistant chronic myeloid leukemia cells | Baran, Yusuf ; Solmaz, Soner; Gökbulut, Aysun ; Kozanoğlu, İlknur; Özdoğu, Hakan |
| Jun-2017 | Effects of cell-mediated osteoprotegerin gene transfer and mesenchymal stem cell applications on orthodontically induced root resorption of rat teeth | Amuk, Nisa Gül; Kurt, Gökmen; Baran, Yusuf ; Seyrantepe, Volkan ; Kartal Yandım, Melis; Adan, Aysun ; Akyıldız Demir, Seçil; Kiraz, Yağmur ; Sönmez, Mehmet Fatih |
| 2009 | The effects of ceramide, glucosylceramide and sphingosine 1 phosphate in resveratrol induced cell death in HL60 acute promyelocytic leukemia cells | Çakır, Zeynep; Saydam, Güray; Şahin, Fahri; Baran, Yusuf |
| 2014 | Effects of hesperidin on non-small cell lung cancer cells | Bireller, Elif Sinem; Cincin, Zeynep Birsu; Ünlü, Miray ; Kıran, Bayram; Baran, Yusuf ; Çakmakoğlu, Bedia |
| Jun-2017 | Effects of intraperitoneal injection of allogeneic bone marrow-derived mesenchymal stem cells on bronchiolitis obliterans in mice model | Işık, Sakine; Uzuner, Nevin; Karaman, Meral; Karaman, Özkan; Kıray, Müge; Kozanoğlu, İlknur; Bağrıyanık, Hüsnü Alper; Arıkan Ayyıldız, Zeynep; Kartal Yandım, Melis; Baran, Yusuf |
| 2015 | Effects of placental derived mesenchymal stem cells on experimental asthma | Sözmen, Çağlayan S.; Karaman, M.; Baran, Yusuf ; Micili, Cilaker S.; Kartal Yandım, Melis; Kiraz, Yağmur ; Karaman, O. |
| 2012 | Enalapril maleate has cytotoxıc effect in HL 60 leukemic cells by altering stat signaling pathway | Şahin, Fahri; Purçlutepe, Özlem; Kiper, Hatice Demet; Tezcanlı, Burçin; Selvi, Nur; Biray Avcı, Çığır; Baran, Yusuf ; Saydam, Güray |
| Jul-2012 | Enalapril-induced apoptosis of acute promyelocytic leukaemia cells involves STAT5A | Purçlutepe, Özlem; İskender, Güniz; Kiper, Hatice Demet; Tezcanlı, Burçin; Selvi, Nur; Biray Avcı, Çığır; Kosova, Buket; Adan Gökbulut, Aysun ; Şahin, Fahri; Baran, Yusuf ; Saydam, Güray |
| Jul-2023 | Examination of therapeutic potential of luteolin on acute lymphoblastic leukemia cells and changes in macromolecules | Çetinkaya, Melisa |
| 2010 | Expression analysis of 84 genes involved in different signalling pathways of cancer in chronic myeloid leukemia cells in response to nilotinib | Baran, Yusuf ; Camgöz, Aylin; Can, Geylani |
| Jan-2015 | Expression levels of bioactive sphingolipid genes in newly diagnosed and drug-resistant chronic myeloid leukemia patients and their impact on the clinical progress | Kartal Yandım, Melis |
| 2014 | Expression levels of ceramide-generating and clearance genes in newly diagnosed and tyrosine kinase inhibitor-resistant chronic myeloid leukemia patients: An attempt to find novel targets | Kartal Yandım, Melis; Kozanoğlu, İlknur; Özdoğu, Hakan; Pişkin, Özden; Özcan, Mehmet Ali; Saydam, Güray; Baran, Yusuf |
| 2014 | Expression levels of ceramide-metabolising genes in newly diagnosed and tyrosine kinase inhibitor-resistant chronic myeloid leukemia (CML) patients: The discovery of novel targets in CML | Yandım, Melis Kartal; Kozanoğlu, İlknur; Özdoğu, Hakan; Pişkin, O.; Özcan, Mehmet Ali; Saydam, Göksel; Baran, Yusuf |
| 2014 | Expression levels of JAK/STAT signaling genes in newly diagnosed, drug sensitive and resistant chronic myeloid leukemia patients | Kiraz, Yağmur |
| 2015 | Expression levels of JAK/STAT signaling genes in newly diagnosed, drug sensitive and resistant chronic myeloid leukemia patients | Kiraz, Yağmur ; Saydam, Güray; Şahin, Fahri; Kozanoğlu, İlknur; Özdoğu, Hakan; Pişkin, Özden; Baran, Yusuf |
| Feb-2017 | Flow cytometry: basic principles and applications | Adan, Aysun ; Alizada, Günel; Kiraz, Yağmur ; Baran, Yusuf ; Nalbant, Ayten |
| Mar-2014 | Fluorine-18 fluorodeoxyglucose PET-CT for extranodal staging of non-Hodgkin and Hodgkin lymphoma | Ömür, Özgür; Baran, Yusuf ; Oral, Aylin; Ceylan, Yeşim |
| 2013 | Fluorine-18-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography for Extranodal Staging of Non-Hodgkin Lymphoma and Hodgkin Disease | Ömür, Özgür; Baran, Yusuf ; Oral, Aylin; Ceylan, Yeşim |
| 2023 | Foreword | Baran, Y. |
| 2010 | Gene expression profiles in resveratrol applied acute promyelocytic leukemia cells | Baran, Yusuf ; Çakır, Zeynep; Can, Geylani; Saydam, Güray; Şahin, Fahri |
| 2010 | Gene expression profiles in resveratrol-induced cell death in acute promyelocytic leukemia cells | Çakır, Zeynep; Can, Geylani; Saydam, Güray; Şahin, Fahri; Baran, Yusuf |
| 2015 | A genome-wide analyses of differentially expressed genes and related networks affected by fisetin and hesperetin in chronic myeloid leukemia cells | Adan Gökbulut, Aysun ; Baran, Yusuf |
| 2013 | Gossypol interferes with both type I and Type II topoisomerase activities without generating strand breaks | Şenarısoy, Müge; Cantürk, Pakize; Zencir, Sevil; Baran, Yusuf ; Topçu, Zeki |
| 2013 | Granulocytic sarcoma: a systematic review | Yılmaz, Asu Fergün; Saydam, Güray; Şahin, Fahri; Baran, Yusuf |
| 2023 | HER2-specific peptide (LTVSPWY) and antibody (herceptin) targeted core cross-linked micelles for breast cancer: A Comparative study | Bayram, N.N.; Ulu, G.T.; Abdulhadi, N.A.; Gürdap, S.; İşoğlu, İ.A.; Baran, Yusuf ; İşoğlu, S.D. |
| 28-Oct-2021 | HER2-targeted, degradable core cross-linked micelles for specific and dual pH-sensitive DOX release | Bayram, Nazende Nur; Ulu, Gizem Tuğçe ; Topuzoğulları, Murat; Baran, Yusuf ; Dinçer İşoğlu, Sevil |
| 2022 | HER2-Targeted, Degradable Core Cross-Linked Micelles for Specific and Dual pH-Sensitive DOX Release | Bayram, N.N.; Ulu, G.T.; Topuzoğulları, M.; Baran, Y. ; Dinçer, İşoğlu, S. |
| 2018 | Hesperidin promotes programmed cell death by downregulation of nongenomic estrogen receptor signalling pathway in endometrial cancer cells | Cincin, Zeynep Birsu; Kıran, Bayram; Baran, Yusuf ; Çakmakoğlu, Bedia |
| 2011 | Hormona dirençli prostat kanseri hücrelerinde dosetaksel ve seramidin induklediği apoptozisde seramid genlerinin ve ürünlerinin eksprersyon düzeylerinin araştırılması | Baran, Yusuf |
| Mar-2011 | Imatinib induces autophagy through BECLIN-1 and ATG5 genes in chronic myeloid leukemia cells | Can, Geylani; Ekiz, Hüseyin Atakan ; Baran, Yusuf |
| 2009 | Imatinib induces autophagy through increasing the expression levels of Beclin-1 and ATG-5 genes in both parental sensitive and imatinib-resistant K562 cells | Baran, Yusuf ; Can, Geylani; Ekiz, Hüseyin Atakan ; Genç, S. G. |
| 6-Dec-2011 | Imatinib-induced apoptosis: A possible link to topoisomerase enzyme inhibition | Baran, Yusuf ; Zencir, Sevil; Çakır, Zeynep; Öztürk, Esra; Topçu, Zeki |
| 2013 | Immunologically detection of BCR/ABL fusion protein with flow cytometry in K562 chronic myeloid leukemia cells and comparison with RT-PCR results | Kozanoğlu, İlknur; Aygün, B.; Boğa, I.; Cansun, C.; Üstündağ, N.; Baran, Yusuf ; Özdoğu, Hakan |
| 2011 | The importance of protein profiling in the diagnosis and treatment of hematologic malignancies | Şanlı Mohamed, Gülşah ; Turan, Taylan; Ekiz, Hüseyin Atakan ; Baran, Yusuf |
| 2010 | Increasing chemosensitivity of chronic myeloid leukemia cells to dasatinib by targeting bioactive sphingolipids | Gencer, Emel Başak |
| 2009 | Increasing de novo synthesis of ceramides increased nilotinib induced apoptosis in human MEG-01 chronic megacaryoblastic cells | Baran, Yusuf ; Gençer, Emel Başak; Ural, Ali Uğur; Avcu, Ferit |
| 2009 | Increasing intracellular generation or accumulation of ceramides increased cytotoxic effects of resveratrol in human k562 chronic myeloid leukemia cells | Kartal Yandım, Melis; Saydam, Güray; Şahin, Fahri; Baran, Yusuf |
| 2014 | Inhibition of jumonji C domain containing histone demethylases in acute myeloid leukemia | Hastar, N.; Koca, D.; Baran, Yusuf |
| Jan-2017 | Intraperitoneal mesenchymal stem cell administration ameliorates allergic rhinitis in the murine model | Işık, Sakine; Karaman, Meral; Adan, Aysun ; Kıray, Müge; Bağrıyanık, Hüsnü Alper; Çağlayan Sözmen, Şule; Kozanoğlu, İlknur; Karaman, Özkan; Baran, Yusuf ; Uzuner, Nevin |
| Jul-2022 | Investigating the potential therapeutic role of targeting STAT3 for overcoming drug resistance by regulating energy metabolism in chronic myeloid leukemia cells | Tezcanlı Kaymaz, Burçin; Günel, Nur Selvi; Söğütlü, Fatma; Özateş Ay, Neslihan Pınar; Baran, Yusuf ; Gündüz, Cumhur; Biray Avcı, Çığır |
| 2014 | Investigation of effects of fisetin, vitexin and hesperetin on chronic myeloid leukemia cells | Adan Gökbulut, Aysun ; Baran, Yusuf |
| 2019 | Investigation of potential anticarcinogenic effects of corilagin in lung cancer cells | Rencüzoğulları, Çağla; Çinçin, Zeynep Birsu; İplik, Elif Sinem; Baran, Yusuf ; Çakmakoğlu, Bedia |
| 2009 | The involvement of ceramide metabolizing genes and their products in docetaxel induced apoptosis in human prostate cancer cells | Başsoy, Esen Yonca |
| 2014 | JAK/STAT Signalling pathway genes in the regulation of tyrosine kinase inhibitors induced and clinical process in chronic myeloid leukemia patients | Kiraz, Yağmur ; Kartal Yandım, Melis; Kozanoğlu, İlknur; Özdoğu, Hakan; Pişkin, I.; Özcan, Mehmet Ali; Saydam, Göksel; Şahin, Fahri; Avcu, Ferit; Ural, Ali Uğur; Ünal, Ali; Baran, Yusuf |
| 2019 | La médecine de précision en oncologie: challenges, enjeux et nouveaux paradigmes | Cox, Stephanie; Rousseau-Tsangaris, Marina; Abou-Zeid, Nancy; Dalle, Stephane; Leurent, Pierre; Cutivet, Arnaud; Baran, Yusuf |
| Aug-2012 | Macromolecular changes in nilotinib resistant k562 cells; An in vitro study by fourier transform infrared spectroscopy | Ceylan, Çağatay ; Camgöz, Aylin; Baran, Yusuf |
| Jul-2016 | Major apoptotic mechanisms and genes involved in apoptosis | Kiraz, Yağmur ; Adan, Aysun ; Kartal Yandım, Melis; Baran, Yusuf |
| 2007 | Mechanisms of cellular resistance to imatinib in human chronic myeloid leukemia cells | Baran, Yusuf ; Ural, Ali Uğur; Gündüz, Ufuk |
| 2010 | The mechanisms responsible for Nilotinib resistance in human chronic myeloid leukemia cells | Camgöz, Aylin |
